Australia sees TNF-inhibitor link with lupus
This article was originally published in Scrip
Executive Summary
Australia's adverse drug reactions advisory committee (ADRAC) says TNF-inhibitors have made up 35 of the 87 adverse drug reactions reports (40%) of drug-induced lupus erythematosus or DILE-like symptoms it has received since 2003 when the first of these drugs was included on the state-funded pharmaceutical benefits scheme (PBS).